LFST Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 -0.91%, SMA50 -2.09%, SMA200 19.98%). The stock’s 14-day RSI is 46.56 (neutral), while the ATR of 0.33 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -16.09% below its high and over 86.1% above its low. Average 10-day trading volume of 9.84 million shares is significantly above the 3-month average of 3.30 million, indicating heightened recent market interest.

LifeStance Health Group, Inc. has 388.94 million shares outstanding. The public float is 140.04 million shares, elevated short interest at 8.59% of float. This equals 7.41 million shares. The short ratio is 3.1 days. Institutional investors hold 99.84% of the float. Insiders own 8.24%. TPG Group Holdings (SBS) Advisors, Inc. holds 175.28 million shares, TPG GP A, LLC has 140.03 million shares and Summit Partners Growth Equity Fund IX-A, L.P. has 41.93 million shares. Over the past six months, insider transactions show net selling. They sold 25.25 million shares across 12 transactions.

Wall Street analysts project EPS growth of 146.62% annually over the next five years. The latest quarter delivered EPS of $0.03. The next quarter is forecast at $0.01. Next year's EPS is expected at $40.59. Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 7 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $12.00 to $8.00. The high target offers 35.59% upside. The low target suggests -9.6% downside. The mean target is $9.55. This offers 7.91% upside. LifeStance Health Group, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended February 25, 2026, missed forecasts by -3291.49%. The prior quarter beat by -307.4%. Over the last six quarters, Apple has recorded several small beats. These include -77.53% in November 07, 2024.

LifeStance Health Group, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $7.69. This means the shares are trading above this model’s fair value.

LifeStance Health Group, Inc. (NASDAQ:LFST) closed at $8.85 USD, gaining $1.49 (20.24%) from the previous close of $7.36. The stock is currently trading near its 52-week high $3.74 and $8.89. With a market capitalization of about $3.43 billion, LifeStance Health Group, Inc. is classified as a mid-cap and shows market-like volatility (beta ~1.20). Key stats such as the average daily volume over the past year has been around 3.09 million shares, trading with heavier-than-usual volume. Headquartered in Scottsdale, AZ, LifeStance Health Group, Inc. operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO David Patrick Bourdon, the company employs approximately 7,535 people and listed since June 10, 2021. LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services.

LifeStance Health Group, Inc. (NASDAQ:LFST) shares are flat 1.99% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows LifeStance Health Group, Inc. trading at a premium to the broader market with a P/E of 145.49. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $9.80, suggesting 10.73% upside. Our AI forecast model points to short-term weakness (-8.93% over two weeks), a medium-term fall (-13.22% over three months), and a longer-term gain (229.49% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that LifeStance Health Group, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -8.93%, with price expected at $8.06 by May 20, 2026, within a range of $7.88 to $8.24 3-Month Outlook: Projected fall of -13.22%, reaching $7.68 by August 04, 2026, with a range of $7.38 to $7.97. 1-Year Outlook: Projected gain of 229.49%, with price at $29.16 by May 06, 2027, within a range of $26.28 to $37.72.

LifeStance Health Group, Inc. trades at a P/E ratio of 145.49, slightly above the S&P 500 average, with a price-to-sales ratio of 2.26 and a price-to-book ratio of 2.28 suggesting the stock is closer to book value. The P/FCF stands at 18.91, also above market averages.